OHSU Knight Cancer Institute announces plans for $100 million gift from Nike Chairman Phil Knight and his wife, Penny
11/22/10 Portland, Ore.
Investments focus on four initiatives to further the institute’s mission to make personalized cancer treatment a reality
Following a thorough exploration and assessment, the Oregon Health & Science University Knight Cancer Institute announced plans for how the $100 million gift from Nike Chairman Phil Knight and his wife, Penny, will further its mission to make personalized cancer therapy a reality.
“We are now in an era where we’re unlocking the secrets of cancer,” said Brian Druker, M.D., director of the OHSU Knight Cancer Institute and associate dean for oncology. The very way we think about cancer is changing, he said, and the $100 million gift goes a long way toward positioning the OHSU Knight Cancer Institute to continue to lead that change and enabling us to leverage the future donations we will need. “The work ahead of us is about much more than scientific discovery and the latest medicine. It’s about sparing families from the fear that this dreaded disease could take away someone they love.”
The gift will be used to launch four initiatives, all of which are designed to transform the OHSU Knight Cancer Institute’s health-care and research operations to deliver personalized cancer therapies. The Knight will expand a “discovery engine” within the university’s research branch to continue to explore the cellular pathways through which cancer grows; enhance the institute’s comprehensive tissue bank for diagnostics and research; establish a clinical molecular lab service; and refine patient care to tailor treatment plans for each individual’s tumor biology. The full OHSU press release is available here.
Pictured: Brian Druker, M.D.